Desai Antal Rohit 4

4 · PROCEPT BioRobotics Corp · Filed Jun 10, 2026

AI-generated summary of this filing

Updated Jun 10, 2026

PROCEPT (PRCT) Director Antal Rohit Desai Receives Awards

What Happened

Antal Rohit Desai, a director of PROCEPT BioRobotics Corp (PRCT), received equity awards on June 9, 2026: 3,315 restricted stock units (RSUs) and a 5,853-share derivative award (stock option). Both grants were issued at $0.00 (no cash paid). Combined, the awards represent potential ownership of 9,168 common shares if all RSUs vest and options are exercised.

Key Details

Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (timely).
Awards: 3,315 RSUs (each RSU converts to one share upon vesting) and a 5,853-share stock option/derivative award; acquisition price listed as $0.00.
Vesting: Both awards vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting following the grant date, subject to continued service.
Shares owned after transaction: Not specified in the provided filing excerpt.
Transaction type code: A = Award/Grant. No sale or purchase reported.

Context

These are grants (compensation), not open-market purchases or sales, so they reflect equity compensation rather than an immediate bullish or bearish trading signal.
RSUs represent a contingent right to receive shares upon vesting; the derivative award is a stock option-type grant that vests on the same schedule. Nothing in the filing indicates immediate sale, tax-withholding, or a 10b5-1 plan.

Form 4

Period: 2026-06-09

Director

Transactions

Award
Common Stock
[F1]
2026-06-09+3,315→ 38,467 total
Award
Stock Option (Right to Buy)
[F2]
2026-06-09+5,853→ 5,853 total
Exercise: $28.78Exp: 2036-06-08→ Common Stock (5,853 underlying)

Footnotes (2)

[F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
[F2]The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

Signature

/s/ Jonathan Stone, Attorney-in Fact for Mr. Antal Rohit Desai|2026-06-10

1 file